scholarly journals Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study.

1992 ◽  
Vol 36 (1) ◽  
pp. 87-91 ◽  
Author(s):  
H L DuPont ◽  
C D Ericsson ◽  
J J Mathewson ◽  
M W DuPont
Keyword(s):  
Controlled Study ◽  
Traveler’S Diarrhea ◽  
Traveler's Diarrhea

Prophylaxis of traveler's diarrhea in Egypt: Results of a double blind controlled study

1991 ◽  
Vol 69 (19) ◽  
pp. 863-866 ◽  
Author(s):  
R. Raedsch ◽  
I. Walter-Sack ◽  
P. R. Galle ◽  
B. Kommerell
Keyword(s):  
Controlled Study ◽  
Double Blind ◽  
Traveler’S Diarrhea ◽  
Traveler's Diarrhea

Blindness and Neuropathy From Diiodohydroxyquin-Like Drugs

PEDIATRICS ◽  
1974 ◽  
Vol 54 (3) ◽  
pp. 378-379
Author(s):  
Sumner J. Yaffe ◽  
C. Warren Bierman ◽  
Howard M. Cann ◽  
Sanford Cohen ◽  
John Freeman ◽  
...  
Keyword(s):  
Young Children ◽  
Optic Atrophy ◽  
Endemic Area ◽  
Chronic Diarrhea ◽  
Acrodermatitis Enteropathica ◽  
Traveler’S Diarrhea ◽  
Traveler's Diarrhea

The halogenated hydroxyquinolines can cause serious, permanent neuropathy. Optic atrophy, causing permanent blindness, is the most commonly reported neuropathy in children. In young children, the onset of neuropathy is insidious and hard to diagnose. We, therefore, recommend that these drugs not be used in children, with two possible exceptions: the treatment of the asymptomatic cyst passer of E. histolytica in a person not living in an endemic area and the treatment of acrodermatitis enteropathica. If used, parents should be informed of the possible toxicity. Parents, child, and physician should diligently search for the first indication of neuropathy. These drugs are contraindicated in the treatment of nonspecific, chronic diarrhea, and "traveler's diarrhea."

PREVENTION OF TRAVELER'S DIARRHEA

1992 ◽  
Vol 6 (2) ◽  
pp. 333-354 ◽  
Author(s):  
Raymond Tellier ◽  
Jay S. Keystone
Keyword(s):  
Traveler’S Diarrhea ◽  
Traveler's Diarrhea
Sign in / Sign up

Export Citation Format

Share Document